Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-25-001686
Filing Date
2025-03-18
Accepted
2025-03-18 16:30:22
Documents
76
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR DEC 2024 xenetic_i10k-123124.htm   iXBRL 10-K 1255553
2 SECURITIES REGISTERED PURSUANT TO SECTION 12 xenetic_ex0401.htm EX-4.1 12553
3 FIRST AMENDMENT TO RESEARCH FUNDING AND OPTION AGREEMENT WITH SCRIPP xenetic_ex1029.htm EX-10.29 10867
4 SECOND AMENDMENT TO RESEARCH FUNDING AND OPTION AGREEMENT xenetic_ex1030.htm EX-10.30 48546
5 CONSULTING AGREEMENT xenetic_ex1031.htm EX-10.31 51673
6 INSIDER TRADING POLICY xenetic_ex1901.htm EX-19.1 116875
7 SUBSIDIARIES xenetic_ex2101.htm EX-21.1 3522
8 INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM CONSENT xenetic_ex2301.htm EX-23.1 2221
9 CERTIFICATION xenetic_ex3101.htm EX-31.1 10676
10 CERTIFICATION xenetic_ex3102.htm EX-31.2 10673
11 CERTIFICATION xenetic_ex3201.htm EX-32.1 4118
17 GRAPHIC image_001.jpg GRAPHIC 51290
  Complete submission text file 0001683168-25-001686.txt   5965592

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE xbio-20241231.xsd EX-101.SCH 34150
13 XBRL CALCULATION FILE xbio-20241231_cal.xml EX-101.CAL 39808
14 XBRL DEFINITION FILE xbio-20241231_def.xml EX-101.DEF 208141
15 XBRL LABEL FILE xbio-20241231_lab.xml EX-101.LAB 351970
16 XBRL PRESENTATION FILE xbio-20241231_pre.xml EX-101.PRE 324695
78 EXTRACTED XBRL INSTANCE DOCUMENT xenetic_i10k-123124_htm.xml XML 633831
Mailing Address 945 CONCORD ST. FRAMINGHAM MA 01701
Business Address 945 CONCORD ST. FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

EIN.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37937 | Film No.: 25748876
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)